| Cellular Physiology and Biochemistry | |
| Tunicamycin Inhibits Diabetes | |
| 关键词: Tunicamycin; Endoplasmic reticulum stress; Oxidative stress; Lymphocytic choriomeningitis virus; Diabetes; | |
| DOI : 10.1159/000338513 | |
| 学科分类:分子生物学,细胞生物学和基因 | |
| 来源: S Karger AG | |
PDF
|
|
【 摘 要 】
Background Autoimmune diseases are characterized by a breakdown of immunologic tolerance, and this breakdown can lead to life-threatening or lifelong disorders. Moreover; drugs that are used to treat these diseases are few in number and are associated with many serious adverse effects. Methods We used the rat insulin promoter-glycoprotein mouse model to analyze the role of tunicamycin in the process of autoimmune diabetes; the P14 mouse model to analyze the effect of tunicamycin on CD8+ T cells; chop knockout mice to analyze the role of tunicamycin on an endoplasmic reticulum stress model; and fluorescence-activated cell sorting, quantitative real-time polymerase chain reaction, and histologic methods. Results We found that a single dose of tunicamycin reduced the activation and pancreatic infiltration of CD8+ T cells. This activity delayed the incidence of virus-induced diabetes and improved survival rates. Conclusion Tunicamycin may offer therapeutic opportunities for T cell-mediated autoimmune diseases such as diabetes.
【 授权许可】
CC BY-NC-ND
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201901239428277ZK.pdf | 951KB |
PDF